![Norman Michael Greenberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Norman Michael Greenberg
Geen lopende functies
Actieve functies van Norman Michael Greenberg
Bedrijven | Functie | Begin | Einde |
---|
Loopbaan van Norman Michael Greenberg
Eerdere bekende functies van Norman Michael Greenberg
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ATRECA, INC. | Hoofd Techniek/Wetenschap/O&O | 01-05-2016 | 31-03-2021 |
CHECKMATE PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-02-2015 | 01-05-2016 |
NMG Scientific Consulting USA | Algemeen Directeur | 01-04-2014 | 01-05-2016 |
President | 01-04-2014 | 01-05-2016 | |
Medimmune, Inc. | Hoofd Techniek/Wetenschap/O&O | 01-08-2011 | 01-05-2014 |
PFIZER, INC. | Hoofd Techniek/Wetenschap/O&O | 01-06-2009 | 01-07-2011 |
Baylor College of Medicine | Corporate Officer/Principal | 01-09-1998 | 01-12-2003 |
Fred Hutchinson Cancer Research Center
![]() Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Fred Hutchinson Cancer Research Center is a non-profit organization which provides research and testing services. The company was founded in 1965 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - | - |
Opleiding van Norman Michael Greenberg
University of Toronto | Undergraduate Degree |
University of British Columbia | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 8 |
Canada | 3 |
Operationeel
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 3 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 4 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
PFIZER, INC. | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Atreca, Inc.
![]() Atreca, Inc. BiotechnologyHealth Technology Atreca, Inc. operates as a clinical-stage biopharmaceutical company, which engages in developing novel antibody-based therapeutics to treat a range of solid tumor types. Its technology leverages next-generation sequencing to identify the set of functional antibodies produced in patients during an immune response. The company was founded by Robert Axtell, Guy Cavet, Jeremy Sokolove, Tito A. Serafini, Paulette A. Dillon, Daniel Emerling, Wayne Volkmuth, Jonathan Woo, Yann Chong Tan, William H. Robinson and Lawrence J. Steinman on June 11, 2010 and is headquartered in San Carlos, CA. | Health Technology |
Checkmate Pharmaceuticals, Inc.
![]() Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA. | Health Technology |
Medimmune, Inc. | Health Technology |
Fred Hutchinson Cancer Research Center
![]() Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Fred Hutchinson Cancer Research Center is a non-profit organization which provides research and testing services. The company was founded in 1965 and is headquartered in Seattle, WA. | Commercial Services |
NMG Scientific Consulting USA |